NASDAQ · Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc (BCRX)
$7.22
-1.37%
37
In band
Moving averages
SMA 200$8.79-17.86%
Company profile
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$1.97B
P/E ratioNone
EPS$-1.28
Beta0.513
Dividend yield0.00%
52-week high$11.22
52-week low$6.23
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 27
CGC
Canopy Growth Corporation
RSI 21
BFRI
Biofrontera Inc
RSI 31
TLRY
Tilray Brands Inc - Class 2
RSI 27
LNTH
Lantheus Holdings Inc
RSI 68
ACB
Aurora Cannabis Inc
RSI 45
ORGO
Organogenesis Holdings Inc - Class A
RSI 38
INM
InMed Pharmaceuticals Inc
RSI 54
RSI alerts for BCRX
An email when BCRX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 3:26 AM EST